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We present a case of iliopsoas abscess secondary to inﬂammatory bowel disease associated to glycogen
storage disease 1b in a 12-year-old boy. To the best of our knowledge, a similar case has not been re-
ported in medical literature.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Glycogen storage disease (GSD) 1b is a rare autosomal recessive
disorder caused by mutation of the gene encoding glucose-6
phosphate translocase (SLC37A4), which functions as transporter
for glucose-6 phosphate across the microsomal membrane [1e3].
The incidence of GSD 1 is 1/100,000 live births and it is estimated
that type 1b represent 15e20% of all cases [4,5]. Affected patients
present at a median age of four months, range 1 daye4 years, with
hepatomegaly, growth retardation, hypoglycemia, lactic acidemia,
hyperuricemia, hyperlipidemia and osteopenia. After some time,
most patients develop neutropenia, considered the characteristic
hallmark of GSD 1b that predisposes to frequent and severe in-
fections and probably to inﬂammatory bowel disease (IBD) [6].1. Case report
A 12-year-old boy, with no signiﬁcant family history, was
admitted to the emergency department with a 24-h history of
abdominal pain and vomiting. He had been diagnosed at 2-month
of age of GSD 1b through liver biopsy, because of persistent hypo-
glycemia, growth retardation and hepatomegaly. A molecular ge-
netic study performed at 6-month of age conﬁrmed the disorderSurgery, University Hospital
, 36312 Vigo, Spain.
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Inc. This is an open access article udetecting a mutation in the SLC37A4 gene. From 2 years of age he
has presented with intermittent neutropenia treated with gran-
ulocyte colony-stimulating factor (GCSF) and from 6 years of age he
has suffered frequent respiratory infections and recurrent IBD
symptoms such as aphthous stomatitis, gingivitis, perianal ab-
scesses, anal ﬁssures, abdominal pain, vomiting and diarrhea. Non-
speciﬁc colitis was diagnosed by colonoscopy and biopsy at 7 years
of age, initiating treatment withmesalazine (5-aminosalicylic acid).
At the time of admission, relevant ﬁndings on physical exam
included thin and pale complexion, notable growth retardation;
height (125 cm) and weight (27 kg) were below the three percen-
tile, and a very protuberant belly. Abdominal palpation revealed
tender right lower abdomen and prominent hepatosplenomegaly.
Computerized tomography (CT) showed massive hep-
atosplenomegaly, marked thickening of the wall of the cecum,
proximal ascending colon and ileum, with mucosal enhancement,
hypodense submucous edema, adjacent mesenteric fat stranding
and engorgement of the vasa recta (Fig. 1). Blood analysis at
admission showed white blood cell count 1.63  109/l, absolute
neutrophil count 0.68  109/l, platelets count 134,000/mcL, he-
moglobin 7.9 g/dl, hematocrit 24.2%, C-reactive protein 210 mg/L
and procalcitonin 6.0 ng/ml. Ileocolitis, neutropenia and anemia in
relation to GSD 1b was diagnosed. Initial medical management
included bowel rest, nasogastric tube decompression, parenteral
nutrition, broad-spectrum antibiotics, and GCSF and mesalazinender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Coronal computed tomography showing massive hepatosplenomegaly, thick-
ening of the cecum and right colon (solid arrows) with mucosal enhancement, hypo-
dense submucous edema (open arrow), adjacent fat stranding (solid head arrow) and
engorgement of the vasa recta (open head arrow).
Fig. 2. Sagittal computed tomography shows gas-containing retroperitoneal abscess
extending from the right renal fossa to the iliac region (arrows).
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evolution, but at 12 days of admission he referred right lumbar pain
irradiating to the groin and anterior thigh. Physical exam revealed
an erythematous, warm and tender right lumbar area suggestive of
cellulitis. CT showed a 4.4  2.2  1.2 cm gas-containing retro-
peritoneal abscess posterior to the right kidney, extending from the
right renal fossa to the iliac region (Fig. 2), with extension and
enlargement to the quadratus lumborum and the iliopsoas muscles
(Fig. 3). US-guided percutaneous drainage only obtained small
amount of purulent exudate and 48-h follow-up CT showed
persistence of the abscess, consequently laparotomy was indicated.
At surgery a severe inﬂammatory process of ileocecal region with
an iliopsoas abscess (IPA) was seen. Drainage of the abscess, bowel
resection and ileocolic anastomosis were performed. All cultures of
exudates obtained in both percutaneous and surgical drainages
were negatives. Pathological study of the resected bowel showed a
non-speciﬁc inﬂammatory process and a ﬁstula in the posterior
aspect of the cecum. Antibiotic treatment was maintained for 14
days after surgery, with favorable evolution.Fig. 3. Axial computed tomography. There is a gas-containing retroperitoneal abscess
(solid arrow) posterior to the right kidney with extension and enlargement to the
quadratus lumborum (open arrow) and the psoas muscles (head arrow).2. Discussion
About 90% of patients with GSD 1b eventually develop neu-
tropenia, being the age at onset variable; in 64% of cases it occurs
before 1 year of age, but in 18% of cases it presented later, between 6
and 9 years of age. Generally, neutropenia is intermittent without a
clear cyclical deﬁned pattern but it can be persistent [4]. In all
evaluated patients with neutropenia, neutrophil function wasabnormal, suggesting that both are closely related. The mechanism
of neutropenia remains unknown, but glucose-6 phosphate trans-
locase (G6PT1) seems to play a role in neutrophil differentiation and
immune modulation, so its defect would be responsible for
neutrophil dysfunction [1e3]. These functional defects include
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cium and abnormal glucose transport and utilization [4,7,8].
Circulating apoptotic neutrophils have been observed in GSD 1b
patients, therefore it has been proposed that apoptosis probably
plays a role in neutropenia development [9].
All GSD 1b patients with neutropenia suffer uncommon, serious
and/or frequent ear, nose and throat, respiratory tract, pyogenic
skin, urinary and gastrointestinal tract infections and deep ab-
scesses, being the most common pathogens Staphylococcus aureus,
Streptococcus pneumonia and Escherichia coli [6,10].
Neutropenia and neutrophil dysfunction probably are causally
related to the pathogenesis of IBD associated to GSD 1b, since IBD
has been only reported in patients with neutropenia, treatment
with GCSF prevents, delays, improves or resolves IBD in some pa-
tients, and other diseases with qualitative and quantitative
neutrophil dysfunction associate similar IBD [4,7,8]. Neutrophil
deﬁciency could lead to chronic low-grade infections of the gut,
which may increase the predisposition to mucosal and bowel
inﬂammation [10].
Chronic or recurrent gastrointestinal symptoms or manifesta-
tions of IBD are present in 77% of the GSD 1b patients, including
chronic or recurrent abdominal pain and diarrhea, perirectal and
perianal ﬁssures, ﬁstulas or abscesses and perioral infections as
aphthous ulcers, periodontitis, gingivitis or abscesses [4]. Inﬂam-
matory lesions can affect anywhere of the gastrointestinal tract,
being the ileocolic region (ileocolitis) the most prevalent site,
probably in relation to the vulnerability of the cecum and ascending
colon because of its distensibility and poor vascular supply [10]. In
some cases IBD is indistinguishable from idiopathic Crohn's disease
by detailed review of clinical, endoscopic and histopathologic
ﬁndings. However, histological exam of affected bowel frequently
reveals non-speciﬁc chronic inﬂammationwithout granulomas nor
cryptitis or crypt abscesses, characteristic of Crohn's disease.
Nevertheless, like Crohn's disease, the segmental, ﬁbrostenotic and
transmural nature of the inﬂammatory process can lead to bowel
narrowing or obstruction secondary to stricture, ﬁstulization and
intraabdominal or perianal abscesses [6,8,10].
IPA is a rare process of difﬁcult diagnosis because of variable and
non-speciﬁc clinical presentation. The classical clinical triad con-
sisting of fever, back pain, and limp is present in only 30% of the
patients. Other symptoms are abdominal and/or ﬂank pain, painful
hip ﬂexion and abdominal or back pain radiation to groin, hip and
thigh [11,12]. Primary IPA occurs as a result of haematogenous
spread from sites of occult infection owing to the rich vascular
supply of muscles, in general associated to immunosuppression
and other predisposing conditions like diabetes, renal failure,
tuberculosis or instrumentations or procedures performed in the
groin, lumbar, or hip areas, being Staphylococcus aureus the most
frequent pathogen [12]. Secondary IPA develops from contiguous
spread, as a complication of underlying disease in adjacent organs
of the gastrointestinal, genitourinary or musculoskeletal systems,
in order of decreasing frequency, being Escherichia coli and strep-
tococcus species the most frequent pathogens. The IPA of gastro-
intestinal origin represents 50% of all secondary cases, being
Crohn's disease the most frequent cause. Other less frequent
gastrointestinal conditions associated to secondary IPA are diver-
ticulitis, appendicitis, colorectal carcinoma and appendiceal tumor
[11,12]. Typhlitis, a necrotizing process usually associated with
immunodeﬁciency and severe neutropenia in relation with inten-
sive chemotherapy for acute leukemia, has been exceptionally
associated to IPA [13].
CT is themodality of choice for diagnosing ileocolitis, its ﬁndings
include ascending colon, cecal and terminal ileum wall thickening,
often with hypodense submucous edema and mucosal enhance-
ment, surrounding fat stranding and engorgement of the vasa recta.Occasionally pericolonic ﬂuid, pneumatosis and intramural hem-
orrhage that increases attenuation of the thickened bowel wall may
be seen. CT ﬁndings correlate well with the clinical ﬁndings and
help in differentiating ileocolitis from other disease processes such
as pseudomembranous colitis, appendicitis, appendiceal abscess or
lymphomatous deposit [11,13].
CT also plays a major role in the diagnosis of pathological con-
ditions involving the psoas muscle and it is considered the most
efﬁcient and accurate imaging modality to demonstrate IPA with a
high sensitivity rate approaching 100%. CT ﬁndings include
enlargement and decreased attenuation of muscle with adjacent fat
stranding. Occasionally, gas can be seen within the IPA, which is
considered a speciﬁc ﬁnding, but has also been found in neoplasms
[11].
Initial medical management typically entails bowel rest,
decompression, broad-spectrum antibiotics, and nutritional sup-
port. Surgery is reserved for those with perforation or clinical
deterioration. Antibiotic treatment in secondary IPA of gastroin-
testinal origin must always be associated to drainage. Percutaneous
drainage is usually considered a ﬁrst-line treatment option but it is
not indicated in the presence of multiloculation or when access to
the cavity is difﬁcult or dangerous. When a ﬁstula is present, the
drainage is not enough to solve the process, and resection of the
affected bowel is required, as in our case. However, percutaneous
drainage may be safely used as initial treatment to improve the
patient's condition before surgery. Antibiotics are generally
continued up to two weeks after complete abscess drainage [11].
3. Conclusion
We report a case of IPA secondary to IBD associated to GSD 1b in
a 12-year-old boy. To the best of our knowledge, a similar case has
not been reported in medical literature. Similar to Crohn's disease,
IBD associated to GSD 1b can progress to ﬁstulization and sec-
ondary IPA.
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